The impact of wild-type reversion on transmitted resistance surveillance

Antivir Ther. 2014;19(7):719-22. doi: 10.3851/IMP2746. Epub 2014 Feb 17.

Authors

David C Boettiger¹, Sasisopin Kiertiburanakul, Somnuek Sungkanuparph, Matthew G Law; TREAT Asia Studies to Evaluate Resistance

Affiliation

¹ Kirby Institute for Infection and Immunity in Society, UNSW Australia, Sydney, New South Wales, Australia. dboettiger@kirby.unsw.edu.au.

PMID: 24535375
PMCID: PMC4135036
DOI: 10.3851/IMP2746

No abstract available

Publication types

Letter
Comment

MeSH terms

Anti-HIV Agents / pharmacology*
Drug Resistance, Viral / genetics*
Female
HIV Infections / virology*
HIV-1 / drug effects*
Humans
Male

Substances

Anti-HIV Agents

Grants and funding

U01 AI069907/AI/NIAID NIH HHS/United States